Cargando…

LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway

Development of chemoresistance is a persistent problem during cancer treatment. Long non-coding RNAs (LncRNAs) are currently emerging as an integral functional component of the human genome and as critical regulators of cancer development and progression. In the present study, we investigated the ro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Qiong-Ni, Wang, Guo, Guo, Ying, Peng, Yan, Zhang, Rui, Deng, Jun-Li, Li, Zhi-Xing, Zhu, Yuan-Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696158/ https://www.ncbi.nlm.nih.gov/pubmed/29190892 http://dx.doi.org/10.18632/oncotarget.21121

Ejemplares similares

CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma
por: Gerardo-Ramírez, Monserrat, et al.
Publicado: (2022)

LncRNA SNHG7 Mediates the Chemoresistance and Stemness of Breast Cancer by Sponging miR-34a
por: Li, Zhi-hua, et al.
Publicado: (2020)

Integrative Analysis of the Doxorubicin-Associated LncRNA–mRNA Network Identifies Chemoresistance-Associated lnc-TRDMT1-5 as a Biomarker of Breast Cancer Progression
por: Chen, Qi, et al.
Publicado: (2020)

Knockdown of lncRNA MCM3AP-AS1 Attenuates Chemoresistance of Burkitt Lymphoma to Doxorubicin Treatment via Targeting the miR-15a/EIF4E Axis
por: Guo, Chao, et al.
Publicado: (2020)

A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance
por: Chen, Lu, et al.
Publicado: (2023)

Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
por: Ahmadpour, Seyedeh Tayebeh, et al.
Publicado: (2023)

LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22
por: Zhu, Kewei, et al.
Publicado: (2020)

LncRNA MIR155HG Overexpression Promotes Proliferation, Migration, and Chemoresistance in Gastric Cancer Cells
por: Lin, Hong, et al.
Publicado: (2023)

Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer
por: Zhu, Liyuan, et al.
Publicado: (2019)

miR‐495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
por: Zou, Zhenyou, et al.
Publicado: (2017)

LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5
por: Xia, Chongsheng, et al.
Publicado: (2022)

Identification of a Prognostic Colorectal Cancer Model Including LncRNA FOXP4-AS1 and LncRNA BBOX1-AS1 Based on Bioinformatics Analysis
por: Shi, Zhi-Liang, et al.
Publicado: (2022)

A chemoresistance lncRNA signature for recurrence risk stratification of colon cancer patients with chemotherapy
por: Wang, Hao, et al.
Publicado: (2021)

PVT1 is a stress-responsive lncRNA that drives ovarian cancer metastasis and chemoresistance
por: Tabury, Kevin, et al.
Publicado: (2022)

Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance
por: Qin, Shuang, et al.
Publicado: (2023)

LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1
por: Huang, Jiayuan, et al.
Publicado: (2020)

DoxoDB: A Database for the Expression Analysis of Doxorubicin-Induced lncRNA Genes
por: Distefano, Rebecca, et al.
Publicado: (2023)

Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma
por: Zhu, Yinghui, et al.
Publicado: (2022)

lncRNA-NRF is a Potential Biomarker of Heart Failure After Acute Myocardial Infarction
por: Yan, Li, et al.
Publicado: (2020)

MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer
por: He, Wanming, et al.
Publicado: (2019)

Mutation of a major CG methylase alters genome-wide lncRNA expression in rice
por: Li, Juzuo, et al.
Publicado: (2021)

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2018)

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2022)

DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells
por: Lee, Yu-Hsien, et al.
Publicado: (2017)

KCNQ1OT1 lncRNA affects the proliferation, apoptosis, and chemoresistance of small cell lung cancer cells via the JAK2/STAT3 axis
por: Zhu, Yaru, et al.
Publicado: (2021)

LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer
por: Zeng, Ying, et al.
Publicado: (2019)

Crizotinib and Doxorubicin Cooperatively Reduces Drug Resistance by Mitigating MDR1 to Increase Hepatocellular Carcinoma Cells Death
por: Shao, Ming, et al.
Publicado: (2021)

LncRNA gadd7, increased in varicocele patients, suppresses cell proliferation and promotes cell apoptosis
por: Zhao, Jun, et al.
Publicado: (2017)

LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM
por: Zhang, Feifei, et al.
Publicado: (2021)

Joint analysis of lncRNA m(6)A methylome and lncRNA/mRNA expression profiles in gastric cancer
por: Lv, Zhi, et al.
Publicado: (2020)

LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1
por: Kun-Peng, Zhu, et al.
Publicado: (2017)

Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis
por: Xue, Sheng, et al.
Publicado: (2022)

LncRNA LINC01535 promotes colorectal cancer development and chemoresistance by sponging miR-761
por: Zhao, Changjie, et al.
Publicado: (2021)

LncRNA NONRATT021972 Was Associated with Neuropathic Pain Scoring in Patients with Type 2 Diabetes
por: Yu, Wei, et al.
Publicado: (2017)

LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability
por: Zhu, Yiran, et al.
Publicado: (2022)

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
por: Zeng, Yunxin, et al.
Publicado: (2021)

Regulation of lncRNA expression
por: Wu, Zhuomin, et al.
Publicado: (2014)

The cullin protein family
por: Sarikas, Antonio, et al.
Publicado: (2011)

Diversification of the cullin family
por: Marín, Ignacio
Publicado: (2009)

Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting the PTN/β-catenin/MDR1 signaling axis by upregulating miR-384
por: Qin, Tao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qb23m76fm0eot2c5ar2nuc7nu4